Testsealabs Malaria Ag P.v Test Cassette
Short Description:
 Rapid Results: Lab-Accurate in Minutes |
Lab-Grade Precision: Reliable & Trustworthy |
| Test Anywhere: No Lab Visit Required |
Certified Quality: 13485, CE, Mdsap Compliant |
| Simple & Streamlined: Easy-to-Use, Zero Hassle |
Ultimate Convenience: Test Comfortably at Home |
Product Introduction: Malaria Ag P.v Test
The Malaria Ag P.v Test is a rapid, qualitative, lateral flow chromatographic immunoassay designed for the specific detection of Plasmodium vivax (P.v) antigens in human whole blood, serum, or plasma. This test aids healthcare professionals in the timely diagnosis of acute malaria infections caused by Plasmodium vivax, one of the most prevalent malaria-causing parasites globally. Utilizing advanced immunochromatographic technology, the assay targets histidine-rich protein-2 (HRP-2) and other P. vivax-specific antigens, providing results within 15–20 minutes. Its high sensitivity and specificity make it an essential tool for early detection in both clinical and resource-limited settings.
Key Features:
- Target-Specific Detection: Precisely identifies Plasmodium vivax antigens, minimizing cross-reactivity with other malaria species (e.g., P. falciparum).
- Rapid Results: Delivers visual, easy-to-interpret results (positive/negative) in under 20 minutes, enabling prompt clinical decisions.
- Multi-Sample Compatibility: Validated for use with whole blood (fingerstick or venous), serum, or plasma specimens.
- High Accuracy: Engineered with monoclonal antibodies for >98% sensitivity and >99% specificity, validated per WHO malaria diagnostic guidelines.
- User-Friendly Workflow: Requires no specialized equipment—ideal for clinics, field deployments, and laboratories.
- Stable Storage: Long shelf life at 2–30°C (36–86°F), ensuring reliability in tropical environments.
Intended Use:
This test is intended for professional in vitro diagnostic use to support the differential diagnosis of Plasmodium vivax malaria. It complements microscopy and molecular methods, particularly in acute phases where rapid treatment initiation is critical. Results should be correlated with clinical symptoms, exposure history, and epidemiological data.
Importance in Clinical Practice:
Early detection of P. vivax malaria reduces the risk of severe complications (e.g., splenomegaly, recurrent relapses) and guides targeted therapy, supporting global efforts toward malaria elimination.
